what are the entrace exams we can give after bsc in biotechnology..???
entrance examination
↧
↧
Scope in biotechnology
Biotechnology is a vast subject it includes all what a loving nature person wish to do.Even i am biotechnology student and my aim is to become genetic engineer
↧
Agril.bsc.Biotechnology
Respected sir, I have just complete bsc. Agril.biotechnology . What is next in bsc. Agril.biotechnology?
↧
Studying Biotechnology courses in India verses abroad?
Hello!
My question is pertaining to whether studying B.sc/ B.Tech Biotechnology in India is worthwhile!? Is The content, context and technology in India at par with other countries!? Does it matter significantly where the person has done the course to get good job opportunities? Please suggest some reputed colleges in Bangalore for undergrad courses in this field. Also, does the course involve math, physics and chemistry as well in the curriculum? Kindly advise.
Regards, minu
My question is pertaining to whether studying B.sc/ B.Tech Biotechnology in India is worthwhile!? Is The content, context and technology in India at par with other countries!? Does it matter significantly where the person has done the course to get good job opportunities? Please suggest some reputed colleges in Bangalore for undergrad courses in this field. Also, does the course involve math, physics and chemistry as well in the curriculum? Kindly advise.
Regards, minu
↧
Better option
Hello!
Which course out of m.sc medical biotechnology or m.sc. biotechnology is having better scope?
Which course out of m.sc medical biotechnology or m.sc. biotechnology is having better scope?
↧
↧
ANY BODY JAM Topper here??
TO all JAM IIT Biotechnology(BT) toppers and who are going to prepare for JAM IIT BT. I have many doubts about competitive exam i.e, JAM IIT BT so, please reply to this message. I want to introduce and share my doubts with you.
Hope,you people clarify my doubts..
Reply soon..just by saying name..![]()
![]()
Hope,you people clarify my doubts..
Reply soon..just by saying name..
↧
Job related query
Hello Sunil sir,
I'm a student a IIT KGP M Tech Biotechnology.Few days ago, i heard that the core companies which come here take 2-3 students out of 24.Other companies which come are from IPR,consultancy and IT.
Though i want to go for a core job, what preparations should be done for getting in IPR and IT companies?
I'm a student a IIT KGP M Tech Biotechnology.Few days ago, i heard that the core companies which come here take 2-3 students out of 24.Other companies which come are from IPR,consultancy and IT.
Though i want to go for a core job, what preparations should be done for getting in IPR and IT companies?
↧
Opportunities for pcb students
Respect Sunil Nagpal sir ,
I have read many answers on Quora.com and on biotechnology forums but still not satisfied.
To be very specific, i am currently doing my 12 boards preparations and i want to do b.tech in biotechnology. My way of thinking is that since i am a pure biology student I thought of doing b.tech in biotechnology from VIT vellore
And after doing b.tech I would apply for gate biotechnology to get an good iit to complete my m.tech .
Is i am thinking correctly?? And what type of problems faced by pure biology student in mathematics during gate ??
Can i get a better and good job after completing my m.tech ??
Plz answer my query so i can start my carrier with better beginning.
I have read many answers on Quora.com and on biotechnology forums but still not satisfied.
To be very specific, i am currently doing my 12 boards preparations and i want to do b.tech in biotechnology. My way of thinking is that since i am a pure biology student I thought of doing b.tech in biotechnology from VIT vellore
And after doing b.tech I would apply for gate biotechnology to get an good iit to complete my m.tech .
Is i am thinking correctly?? And what type of problems faced by pure biology student in mathematics during gate ??
Can i get a better and good job after completing my m.tech ??
Plz answer my query so i can start my carrier with better beginning.
↧
Opportunities in computational biology.
Hello sir,
I m Shweta biotech 4th year student
Could u give me some information about that how can i get good jobs in india if my interest in bioinformatics..
And also good colleges for PG
I m Shweta biotech 4th year student
Could u give me some information about that how can i get good jobs in india if my interest in bioinformatics..
And also good colleges for PG
↧
↧
Opportunities in India [emoji1128] and abroad
Respected Sunil Sir ,
I was very comfortable with your answer that you wrote.
Since I am an aspirant of biotechnology , i read your answers on jobs in india for biotechnology students .
To be very specific and straightforward i want to ask you that what are the jobs opportunities in abroad in countries like USA![]()
UAE![]()
( I heard of duBiotech park in dubai ,does it gives jobs to m.tech graduates?)
etc.
After M.Tech from good IIT
Since i am not too much interested in pay scale (salaries) but still i want to know that what are the salaries they give to indian students .
And what is the average and highest package in India![]()
after M.tech and abroad .
Thanking You.
Prateek Parihar
![]()
I was very comfortable with your answer that you wrote.
Since I am an aspirant of biotechnology , i read your answers on jobs in india for biotechnology students .
To be very specific and straightforward i want to ask you that what are the jobs opportunities in abroad in countries like USA
UAE
( I heard of duBiotech park in dubai ,does it gives jobs to m.tech graduates?)etc.
After M.Tech from good IIT
Since i am not too much interested in pay scale (salaries) but still i want to know that what are the salaries they give to indian students .
And what is the average and highest package in India
after M.tech and abroad . Thanking You.
Prateek Parihar
↧
What are the important microbes that useful in bioremediation process!??
Plz suggests some answer
↧
Jobs after Bsc. Biotechnology
I'm Niharuddin... Shortly called as Nikki ... I'm studying now final year .... In Pondicherry . I'm feeling confused that what I have to do after my UG studies.. ?? Is there is any scope (jobs) after Bsc.biotechnology?? Plz suggest me some answer... . your answer will be a great hope for me..![]()
↧
Preparation for IITJAM and CBEE
How to prepare for IIT JAM and CBEE ..?? i mean pls help me with some books i could refer and some of the coaching clases in bangalore
↧
↧
Is there any forums available write now for scholarships in abroad?
Hello, i am looking for the different universities entrance forums of top universities all around the globe for indian students...
↧
GATE 2017 BIOTECHNOLOGY
I am going to sit for GATE 2017 (BT). My query is what is a good GATE percentile to get a good institute for m.tech or phD?
↧
Ebola Vaccine with 100% Protection
Prologue:
'In a study published (on Thursday, 22nd December 2016) , an experimental (rVSV-vectored) vaccine against the Ebola virus has been found to be 100% effective! This study and its results have emerged as a great sigh of relief not only for Africa (this disease created havoc in 2014 by causing death of over 11,000 people!) but also......'
If you find it interesting and worth sharing, please do spread the news in your social network.
In a study published in 'The Lancet' (on Thursday, 22nd December 2016) , an experimental (rVSV-vectored) vaccine against the Ebola virus has been found to be 100% effective!
<div style="display: table-cell"><div><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/7/78/Study_Participant_Receives_NIAID-GSK_Candidate_Ebola_Vaccine.jpg/320px-Study_Participant_Receives_NIAID-GSK_Candidate_Ebola_Vaccine.jpg" alt="no longer available" style="float: left;padding-right:12px"></div>
This study and its results have emerged as a great sigh of relief not only for Africa (this disease created havoc in 2014 by causing death of over 11,000 people!), but also for the entire world where the Ebola Virus has been spreading ceaselessly. As quoted by Dr. KeÏta Sakoba, director of Guinea's 'National Agency for Health Security'.
About this 'Ebola Vaccine'
rVSV-ZEBOV, the vaccine used in the study, is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus.
In this study, the effect of rVSV-ZEBOV in preventing Ebola virus disease in contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa was tested.
Following is the brief of their story:
In 2015, this experimental vaccine was administered to residents of Guinea 'who were in contact with patients who had recently confirmed cases of Ebola'.
Few months post these early trials, the WHO identified the preliminary results of the trials as an “extremely promising development.”
The trial involving > 11000 people, was later led by WHO in conjunction with Guinea’s Ministry of Health.
Total 5,837 people were administered the rVSV-ZEBOV vaccine, and none recorded any case of Ebola post 10 days or longer.
Vaccine side effects in some subjects were observed, but were limited to headaches, fatigue and muscle pain. Two subjects had serious reactions, one who having an allergic reaction.
Ring strategy of this study for 100% Effective Ebola Vaccine
Ebola is not new to the world (first discovered in 1976). Being limited to isolated African communities for almost 3 decades, its outbreaks were always manageable, and hence wasn't considered a major threat.
But, in 2014, a major outbreak took place, wherein Ebola virus reached cities and started spreading like wildfire (catching the entire global health community off guard and clueless about this sudden and huge outbreak). From Africa, it started spreading to other continents/countries/states/cities and countrysides. This called for a concerted effort.
Categorized as a highly contagious virus, Ebola can spread once patients are symptomatic. So, the relatives of the patients are at great risk of exposure while they try to take care of their loved ones. With an aim to combat this, researchers designed the vaccine administration approach in such a way that the Ebola Vaccine should be doled out to "clusters” or “rings” — groups of people who had been in contact with an Ebola patient (same strategy that was used to eradicate smallpox).
The logic behind this approach, as explained by John-Arne Rottingen of the Norwegian Institute of Public Health to CNN is quite legit:
Merck, Sharp & Dohme manufactured the vaccine for the trial and are producing for further actions as well.
As per the promise of Merck: 300,000 doses of the vaccine will be available in case of a new Ebola flareup. Merck will be submitting the Ebola vaccine for licensing by the close of 2017.
Following is the entire research paper published in "The Lancet":
![.pdf]( "Adobe Acrobat PDF")
EbolaVaccine100%Protecion.pdf (Size: 857.3 KB / Downloads: 0)
<form action="http://www.biotechnologyforums.com/thread-7210.html">
<input type="submit" value="Ebola Virus Details" class="btn btn-info" style="height:30px;background:#005EA7;color:white;cursor:pointer;font-weight:bold;border:none">
</form>
'In a study published (on Thursday, 22nd December 2016) , an experimental (rVSV-vectored) vaccine against the Ebola virus has been found to be 100% effective! This study and its results have emerged as a great sigh of relief not only for Africa (this disease created havoc in 2014 by causing death of over 11,000 people!) but also......'
If you find it interesting and worth sharing, please do spread the news in your social network.
In a study published in 'The Lancet' (on Thursday, 22nd December 2016) , an experimental (rVSV-vectored) vaccine against the Ebola virus has been found to be 100% effective!
<div style="display: table-cell"><div><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/7/78/Study_Participant_Receives_NIAID-GSK_Candidate_Ebola_Vaccine.jpg/320px-Study_Participant_Receives_NIAID-GSK_Candidate_Ebola_Vaccine.jpg" alt="no longer available" style="float: left;padding-right:12px"></div>
This study and its results have emerged as a great sigh of relief not only for Africa (this disease created havoc in 2014 by causing death of over 11,000 people!), but also for the entire world where the Ebola Virus has been spreading ceaselessly. As quoted by Dr. KeÏta Sakoba, director of Guinea's 'National Agency for Health Security'.
Quote:Ebola left a devastating legacy in our country. We are proud that we have been able to contribute to developing a vaccine that will prevent other nations from enduring what we endured”</div>
About this 'Ebola Vaccine'
rVSV-ZEBOV, the vaccine used in the study, is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus.
In this study, the effect of rVSV-ZEBOV in preventing Ebola virus disease in contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa was tested.
Following is the brief of their story:
In 2015, this experimental vaccine was administered to residents of Guinea 'who were in contact with patients who had recently confirmed cases of Ebola'.
Few months post these early trials, the WHO identified the preliminary results of the trials as an “extremely promising development.”
The trial involving > 11000 people, was later led by WHO in conjunction with Guinea’s Ministry of Health.
Total 5,837 people were administered the rVSV-ZEBOV vaccine, and none recorded any case of Ebola post 10 days or longer.
Vaccine side effects in some subjects were observed, but were limited to headaches, fatigue and muscle pain. Two subjects had serious reactions, one who having an allergic reaction.
Ring strategy of this study for 100% Effective Ebola Vaccine
Ebola is not new to the world (first discovered in 1976). Being limited to isolated African communities for almost 3 decades, its outbreaks were always manageable, and hence wasn't considered a major threat.
But, in 2014, a major outbreak took place, wherein Ebola virus reached cities and started spreading like wildfire (catching the entire global health community off guard and clueless about this sudden and huge outbreak). From Africa, it started spreading to other continents/countries/states/cities and countrysides. This called for a concerted effort.
Categorized as a highly contagious virus, Ebola can spread once patients are symptomatic. So, the relatives of the patients are at great risk of exposure while they try to take care of their loved ones. With an aim to combat this, researchers designed the vaccine administration approach in such a way that the Ebola Vaccine should be doled out to "clusters” or “rings” — groups of people who had been in contact with an Ebola patient (same strategy that was used to eradicate smallpox).
The logic behind this approach, as explained by John-Arne Rottingen of the Norwegian Institute of Public Health to CNN is quite legit:
Quote:“The premise is that by vaccinating all people who have come into contact with an infected person, you create a protective ‘ring’ and stop the virus from spreading further”After this huge reported success, the Ebola vaccine production has been fast tracked by US and European regulatory agencies.
Merck, Sharp & Dohme manufactured the vaccine for the trial and are producing for further actions as well.
As per the promise of Merck: 300,000 doses of the vaccine will be available in case of a new Ebola flareup. Merck will be submitting the Ebola vaccine for licensing by the close of 2017.
Following is the entire research paper published in "The Lancet":
EbolaVaccine100%Protecion.pdf (Size: 857.3 KB / Downloads: 0)
<form action="http://www.biotechnologyforums.com/thread-7210.html">
<input type="submit" value="Ebola Virus Details" class="btn btn-info" style="height:30px;background:#005EA7;color:white;cursor:pointer;font-weight:bold;border:none">
</form>
Science and Biotechnology has yet again proved its worth to life and living forms.
↧
Topic discerson
Lab who is topic give
↧
↧
Seahawks say their decision to limit
NEW YORK -- Curtis Granderson envisioned a bunch of big hits when he signed with the New York Mets. Mike Webster Steelers Jersey . Providing even one proved elusive, until Friday night. The slumping Granderson grounded an RBI single to cap an improbable two-run rally with two outs in the ninth inning that sent the Mets past the Miami Marlins 4-3. "Anytime you get a chance to win and jump up and down with your teammates, its a good thing," Granderson said. Granderson was 0 for 4 when he stepped to the plate with the scoreboard showing his batting average at .130. Not quite what anyone expected for a former All-Star fresh off a $60 million, four-year contract. "Im not there yet, but Im getting closer," Granderson said. After Jarrod Saltalamacchia and Garrett Jones hit back-to-back home runs in the Miami eighth for a 3-2 lead, the Mets stung Marlins closer Steve Cishek and won for the fifth time in six games. Cishek (1-1) had converted a team-record 33 straight save chances -- the longest active streak in the majors -- before Lucas Duda led off the ninth with a soft single and moved up on a sacrifice. Left fielder Christian Yelich made a nice running catch on pinch-hitter Bobby Abreus liner for the second out. Omar Quintanilla followed with a single down the line and Yelich slipped on the dirt as he got ready to throw home, letting Duda score standing up. "It wouldve been a tough play," Yelich said. "But if I had stayed on my feet, I was going home." Pinch-hitter Kirk Nieuwenhuis doubled to put runners at second and third. Granderson then grounded his game-winner past Jones at first base. "Ill be up a while," the sidearming Cishek said. "Its never a good feeling." "Its no excuse for me to come in and not get the job done," he said. "I just didnt have my good command, leaving pitches down the middle." Granderson had a game-winning sacrifice fly in the 14th inning Sunday against Atlanta. "Hes a great hitter," Marlins manager Mike Redmond said. "Just because he hasnt gotten a whole lot of hits to this point doesnt mean hes not a great hitter." Redmond felt confident Cishek would close out the Mets. "Hes been so good," Redmond said. "I always anticipate hes going to get out of it. And tonight, he didnt." "You just see the momentum starting to roll their way and we couldnt stop it," he said. Jeurys Familia (1-2) pitched a scoreless inning for his first big league win. Yelichs hitting streak ended at 17 games, and the Marlins fell to 1-9 on the road. Saltalamacchia homered to left-centre off reliever Gonzalez Germen, and Jones followed with a drive off the right-field foul pole. The Mets hadnt allowed any home runs since last Saturday, a span of 57 innings. Young starters Zack Wheeler and Henderson Alvarez both pitched well. Wheeler, a month before he turns 24, struck out 10 in six innings. He gave up four singles and walked three in six innings. Wheeler showed off his repertoire when he fanned the side in the third, all on swinging strike three -- he got Alvarez on a fastball, Yelich on a changeup and Marcell Ozuna on a curve. A week past his 24th birthday, Alvarez gave up two runs in six innings. In his previous start, he pitched a two-hit shutout against Seattle. David Wright hit an RBI single and scored on Daniel Murphys double in the third to put the Mets ahead 2-0. Ozuna hit an RBI single in the fifth that made it 2-1. NOTES: Marlins RHP Kevin Slowey (0-0, 4.15 ERA) is set to start Saturday night against RHP Jenrry Mejia (3-0, 1.99). ... Cishek had converted his first four save chances this season. ... In the last 11 games, no Mets starter has allowed more than three runs. ... Murphy stole third, and has been safe on his last 26 tries.Stephon Tuitt Steelers Jersey . Pospisil, the seventh seed, saved match points in each of the last two sets before falling to the unseeded Dutchman. "I wasnt very happy with the way I was playing,"said Pospisil. Markus Wheaton Steelers Jersey . Onyshko, from Minnedosa, Man., will compete in artistic gymnastics while Hanet, from Kelowna, B.C., will compete in lawn bowling as a para-athlete. "It is exciting that our Canadian athletes are starting to arrive at the Games Village," said Chantal Petitclerc, Canadas Chef de Mission.RENTON, Wash. - The Seattle Seahawks say their decision to limit ticket sales for the NFC championship game to certain states was due to concerns over ticket brokers. The Seahawks sold out a small allotment of available tickets — less than 3,000 — in less than 30 minutes Monday. The team has taken heat for excluding fans with billing addresses in California from purchasing tickets to Sundays game between the Seahawks and San Francisco. The team says that when tickkets went on sale for the playoff game against New Orleans, brokers had found a way to manipulate the system and acquire most of them, then increasing the price on the open market. Javon Hargrave Steelers Jersey. Seattle announced its decision to limit sales to those with billing addresses in Washington, Oregon, Idaho, Montana, Hawaii, Alaska and the Canadian provinces of British Columbia and Alberta after Saturdays win over New Orleans and before the Seahawks knew their opponent. Cheap NFL Jerseys nfl jerseys china ' ' '
↧
Concerned about your career growth?
You are a well qualified professional from world’s top institution, with skills, expertise, and achievements but you do not see it contributing to your career growth. What you need is a digital platform where you can showcase all your achievements . RockON is a platform that will help you grow, create your brand and make you a well-known professional. To know how it works, Sign-up today at https://www.rockon.me/
↧
Polymer for controlled diffusion of glucose
Hey guys,
I'm trying to find a polymer for a controlled diffusion of glucose. Currently, I am using membrane systems, but I have to punch them manually and handle them with a tweezer so that it could happen that the membranes are being harmed which leads to different pore distribution.
Is there a reliable way to produce polymer matrices for controlled diffusion of glucose in a reliable and reproducible way?
Best Regards,
Moe
I'm trying to find a polymer for a controlled diffusion of glucose. Currently, I am using membrane systems, but I have to punch them manually and handle them with a tweezer so that it could happen that the membranes are being harmed which leads to different pore distribution.
Is there a reliable way to produce polymer matrices for controlled diffusion of glucose in a reliable and reproducible way?
Best Regards,
Moe
↧
More Pages to Explore .....
